Agronomed Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Agronomed Pharmaceuticals LLC is committed to advancing the Medical Cannabis industry with a primary focus on developing and researching products targeted for specific indications for the best medical efficacy. Cannabis contains more than 480 chemical compounds and more than 80 currently known to only exist in the c cannabis plant, some countries such as Israel and Great Britain have been more liberal in allowing or funding cannabis research and are currently at the forefront of the research currently available. It is Agronomed's mission to help the US catch up in cannabis based or infused product development and ultimately become a leader in the national and global release of proven pharmaceutical products containing cannabis compounds. The large number of chemical compounds that can be present in cannabis enables advancements in product efficacy to be best achieved through a combination of the appropriate, non-biased studies of product chemical profiles mapped to patient outcomes for specific ailments in conjunction with continual application and focus on the aspects of biochemistry and bio-genetics to focus the products and studies accordingly. It is our mission to develop effective formulations based on Biochemistry and Bio-Genetics, drive patient based clinical trials needed to improve or refine those formulations, leverage technology to analyze data collected related to patient outcomes and feed that data back into the product development life cycle.
Agronomed Pharmaceuticals has raised $7.1M across 1 funding round on record, the most recent an undisclosed round of $7.1M announced in Dec 2022.
That round is above the $2.3M median round size for Community and Lifestyle companies tracked on FundedIQ over the last two years.
Agronomed Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Agronomed Pharmaceuticals Funding Rounds
Agronomed Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Agronomed Pharmaceuticals Funding Compared to Other Community and Lifestyle Startups
Agronomed Pharmaceuticals' latest round of $7.1M is above the median round in Community and Lifestyle. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Agronomed Pharmaceuticals in Community and Lifestyle and Exton
Companies Similar to Agronomed Pharmaceuticals
Petfolk is a veterinary healthcare organization that offers an integrated platform for veterinarians, pets,…
MERIT Beauty is a cosmetic brand company that offers luxury skincare products. The company was founded in…
Wagmo is a fantastic service that basically provides reimbursement for doing all the things that we already…
HelloVote is a developer of voter engagement platform simplifying registration, election information, and…
Women's Health Center of West Virginia is a private nonprofit healthcare facility that provides reproductive…
Los Sundays is a lifestyle brand disrupting a product-focused category. Strategically built to engage…
Skiptown (formerly Skipper) is a tech-enabled hub for dogs and their people. The trusted pet services company…
Nicol is an operator of multi-racquet sports clubs offering fitness and community.
Self-Help Enterprises is an organization dedicated to self-help housing, sewer and water development, housing…
Georgia Banking Company is a financial services community bank that engages in the wholesale mortgage…
Ensemble Hotel Partners is a real estate company that envisions, manages, brokers, and owns transformative…
Creature Comforts ADK is a boutique pet supplies store.
Agronomed Pharmaceuticals Funding FAQs
What does Agronomed Pharmaceuticals do?
Agronomed Pharmaceuticals LLC is committed to advancing the Medical Cannabis industry with a primary focus on developing and researching products targeted for specific indications for the best medical efficacy. Cannabis contains more than 480 chemical compounds and more than 80 currently known to only exist in the c cannabis plant, some countries such as Israel and Great Britain have been more liberal in allowing or funding cannabis research and are currently at the forefront of the research currently available. It is Agronomed's mission to help the US catch up in cannabis based or infused product development and ultimately become a leader in the national and global release of proven pharmaceutical products containing cannabis compounds. The large number of chemical compounds that can be present in cannabis enables advancements in product efficacy to be best achieved through a combination of the appropriate, non-biased studies of product chemical profiles mapped to patient outcomes for specific ailments in conjunction with continual application and focus on the aspects of biochemistry and bio-genetics to focus the products and studies accordingly. It is our mission to develop effective formulations based on Biochemistry and Bio-Genetics, drive patient based clinical trials needed to improve or refine those formulations, leverage technology to analyze data collected related to patient outcomes and feed that data back into the product development life cycle.
How much funding has Agronomed Pharmaceuticals raised?
Agronomed Pharmaceuticals has raised $7.1M across 1 round on record. The most recent is an undisclosed round of $7.1M announced in Dec 2022.
When did Agronomed Pharmaceuticals last raise funding?
Agronomed Pharmaceuticals' most recent funding round on record is an undisclosed round of $7.1M, announced in Dec 2022.
Who is the CEO of Agronomed Pharmaceuticals?
Jon Cohn is listed as CEO at Agronomed Pharmaceuticals.
Where is Agronomed Pharmaceuticals headquartered?
Agronomed Pharmaceuticals is based in Exton, Pennsylvania, United States.
How many employees does Agronomed Pharmaceuticals have?
Agronomed Pharmaceuticals is in the 1-10 employee band.
How does Agronomed Pharmaceuticals' funding compare to other Community and Lifestyle startups?
Agronomed Pharmaceuticals' latest round of $7.1M is above the $2.3M median round size for Community and Lifestyle companies on FundedIQ across 1,484 tracked companies over the last two years.
About FundedIQ's Agronomed Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Agronomed Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.